Replies to post #431021 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Agreed. Also, if they intended to stay independent they would have at least started to put some job postings for sales, marketing & business development team, considering they are sitting on the cusp of a major disruptive technology reveal and imminent change of standard of care.

Or they know it will be a CDMo and that is why the hiring is for those jobs.

2022 will be the year where all the hype is on manufacturing and DCVax-L becomes another resident up in the attic with the other failed DCVax products.

[HappyLibrarian]

I wouldn’t trust anyone that says they don’t need a sales/marketing and business dev team to promote and capture market share for DCVAX-L regardless of how good the results and technology are both in terms of safety and efficacy.

There are probably plenty of out-of-work sales reps from Purdue Pharma

[skitahoe]

Mav,

I believe that they will attract more qualified people by waiting for the Journal, and then they will still have sufficient time to build up the work force. We still don't know how soon they intend to file the BLA, that's when they need to start building.

Gary

[Poor Man -]

And further to your point, if I’m understand the current state of play correctly - they don’t even have a CDMO contract any longer for the US. As if to say, those negotiations will be handled by the eventual buyer. No longer our call.

[Kam8]

Good point. Fingers crossed